The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fausch, S. C.
Right arrow Articles by Kast, W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fausch, S. C.
Right arrow Articles by Kast, W. M.
The Journal of Immunology, 2005, 174: 7172-7178.
Copyright © 2005 by The American Association of Immunologists

Human Papillomavirus Can Escape Immune Recognition through Langerhans Cell Phosphoinositide 3-Kinase Activation1

Steven C. Fausch, Laura M. Fahey, Diane M. Da Silva and W. Martin Kast2

Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089

Human papillomavirus (HPV) infection of cervical epithelium is linked to the generation of cervical cancer. Although most women infected with HPV clear their lesions, the long latency period from infection to resolution indicates that HPV evolved immune escape mechanisms. Dendritic cells, which are targeted by vaccination procedures, incubated with HPV virus-like particles induce an HPV-specific immune response. Langerhans cells (LC), which are located at the sites of primary infection, do not induce a response implicating the targeting of LC as an immune escape mechanism used by HPV. LC incubated with HPV virus-like particles up-regulate the phosphoinositide 3-kinase (PI3-K) pathway and down-regulate MAPK pathways. With the inhibition of PI3-K and incubation with HPV virus-like particles, LC initiate a potent HPV-specific response. PI3-K activation in LC defines a novel escape mechanism used by HPV, and PI3-K inhibition may serve as an effective clinical target to enhance HPV immunity.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. M. Fahey, A. B. Raff, D. M. Da Silva, and W. M. Kast
A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune Escape
J. Immunol., November 15, 2009; 183(10): 6151 - 6156.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Fahey, A. B. Raff, D. M. Da Silva, and W. M. Kast
Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16
J. Immunol., March 1, 2009; 182(5): 2919 - 2928.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. L. Ferris and J. R. Grandis
NF-{kappa}B Gene Signatures and p53 Mutations in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., October 1, 2007; 13(19): 5663 - 5664.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
U. A. Hasan, E. Bates, F. Takeshita, A. Biliato, R. Accardi, V. Bouvard, M. Mansour, I. Vincent, L. Gissmann, T. Iftner, et al.
TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16
J. Immunol., March 1, 2007; 178(5): 3186 - 3197.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. M. LeBlanc, M. M. Barousse, and P. L. Fidel Jr.
Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis.
Infect. Immun., June 1, 2006; 74(6): 3213 - 3221.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.